Smith & Nephew plc (NYSE:SNN) Receives Consensus Rating of “Moderate Buy” from Analysts

Shares of Smith & Nephew plc (NYSE:SNNGet Free Report) have earned a consensus rating of “Moderate Buy” from the six ratings firms that are currently covering the company, MarketBeat.com reports. Three research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company.

Separately, StockNews.com raised shares of Smith & Nephew from a “buy” rating to a “strong-buy” rating in a research report on Friday, March 15th.

View Our Latest Report on Smith & Nephew

Smith & Nephew Stock Down 1.1 %

NYSE SNN opened at $24.27 on Friday. The company has a current ratio of 1.77, a quick ratio of 0.72 and a debt-to-equity ratio of 0.44. The company has a 50 day moving average price of $27.39 and a two-hundred day moving average price of $26.06. Smith & Nephew has a 12-month low of $21.52 and a 12-month high of $33.08.

Smith & Nephew Announces Dividend

The company also recently announced a semi-annual dividend, which will be paid on Wednesday, May 22nd. Stockholders of record on Tuesday, April 2nd will be paid a $0.462 dividend. The ex-dividend date of this dividend is Monday, April 1st. This represents a dividend yield of 2.8%.

Institutional Investors Weigh In On Smith & Nephew

Several institutional investors and hedge funds have recently made changes to their positions in the company. Scharf Investments LLC lifted its position in Smith & Nephew by 20.5% during the 4th quarter. Scharf Investments LLC now owns 2,980,334 shares of the medical equipment provider’s stock worth $81,304,000 after buying an additional 506,474 shares in the last quarter. PNC Financial Services Group Inc. lifted its position in Smith & Nephew by 17.4% during the 3rd quarter. PNC Financial Services Group Inc. now owns 36,315 shares of the medical equipment provider’s stock worth $900,000 after buying an additional 5,384 shares in the last quarter. American Century Companies Inc. lifted its position in Smith & Nephew by 343.5% during the 3rd quarter. American Century Companies Inc. now owns 2,364,037 shares of the medical equipment provider’s stock worth $58,557,000 after buying an additional 1,830,965 shares in the last quarter. Legacy Wealth Asset Management LLC lifted its position in Smith & Nephew by 3.8% during the 3rd quarter. Legacy Wealth Asset Management LLC now owns 15,026 shares of the medical equipment provider’s stock worth $372,000 after buying an additional 546 shares in the last quarter. Finally, Hsbc Holdings PLC acquired a new position in Smith & Nephew during the 3rd quarter worth about $8,174,000. Institutional investors and hedge funds own 25.64% of the company’s stock.

About Smith & Nephew

(Get Free Report

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.

Featured Stories

Analyst Recommendations for Smith & Nephew (NYSE:SNN)

Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.